Overview
- 6 public-safe observations are available for this inspection.
- 6 structured CFR citations are represented.
- 5 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
Absence of Written Procedures
Cited by Wayne E Seifert, Daniel L Zheng, Ogechi C Nna, Armen H Youssoufian, Talia A Faison
Procedures for sterile drug products
Cited by Wayne E Seifert, Daniel L Zheng, Ogechi C Nna, Armen H Youssoufian, Talia A Faison
Investigations of discrepancies, failures
Cited by Wayne E Seifert, Daniel L Zheng, Ogechi C Nna, Armen H Youssoufian, Talia A Faison
Buildings not maintained in good state of repair
Cited by Wayne E Seifert, Daniel L Zheng, Ogechi C Nna, Armen H Youssoufian, Talia A Faison
Equipment Design, Size and Location
Cited by Wayne E Seifert, Daniel L Zheng, Ogechi C Nna, Armen H Youssoufian, Talia A Faison
Inspected site
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.58 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 6 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere